Here is a link to a British study abstract about another new, anti-myeloma drug:
EntreMed’s ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models.
The study results were published in the British Journal of Haematology.
ENMD-2076 is another variation of a kinase inhibitor. Lots of research going on worldwide using kinase inhibitors against multiple myeloma. Hopefully some of this preliminary research sticks!
Feel good and keep smiling! Pat